Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Stewart, Douglas A
  • Shepherd, Lois E
  • Dudebout, Jill J
  • Larouche, Jean-François
  • Chua, Neil
  • Baetz, Tara
  • Crump, Michael
  • Shafey, Mona
  • Abdel-Samad, Nizar
  • Robinson, Sue
  • Fleury, Isabelle
  • Marcellus, Deborah
  • Skrabek, Pamela
  • Kelly, Jesse
  • Hay, Annette E
  • Chen, Bingshu
  • Kuruvilla, John

publication date

  • November 15, 2022

published in